Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Sonoma Biotherapeutics
400 E. Jamie Ct, Suite 202
South San Francisco, CA 94080

Sonoma Biotherapeutics is a privately held company leading the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of Treg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies.

Key Contact
Jeffrey Bluestone, PhD
Founder, President & CEO
Funding Events

02/06/20 $40,000,000 Series A 8VC
ARCH Venture Partners
Lyell Immunopharma
Milky Way Ventures